ElkosRx, LLC
PrivateLast Round
Follow-on Offering
Jun 10, 2026
Total Funding Raised
$139.18M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ElkosRx, LLC is a biotechnology company developing a topical treatment for early-stage diabetic foot ulcers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ElkosRx, LLC Comparables
Compare ElkosRx, LLC with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Remedor Biomed Ltd. | 84% | |
| Lynch Regenerative Medicine | 82% | |
| Aurealis Therapeutics | 78% |
ElkosRx, LLC Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Follow-on Offering | Jun 10, 2026 | ||||
| Debt | Jul 10, 2024 | ||||
| PIPE | Sep 20, 2023 | ||||
| Debt | Oct 5, 2021 | ||||
| Series C | Aug 2, 2017 |
ElkosRx, LLC Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Hercules Capital | Debt |
| DSC Investment | Series C |
| EQT Life Sciences | Series C |
| Korea Investment Partners | Series C |
| Pontifax Venture Capital | Series C |
| OPKO Health | Series C |
| Quark Venture | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 10, 2026
$66M raised in follow-on offering.
- Sep 20, 2023
Raised $2M in a PIPE round.
ElkosRx, LLC Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ElkosRx, LLC's valuation, stock price, and market status.
Is ElkosRx, LLC a public or private company?
ElkosRx, LLC is a private company.
What is the current stock price of ElkosRx, LLC?
ElkosRx, LLC is a private company with no public stock price. Caplight tracks ElkosRx, LLC's secondary market activity and provides MarketPrice estimates to Caplight users.
How much is ElkosRx, LLC worth (valuation)?
Valuation information for ElkosRx, LLC is not publicly available.
Can I buy ElkosRx, LLC stock?
ElkosRx, LLC shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ElkosRx, LLC's last funding round?
ElkosRx, LLC's most recent funding round was Follow-on Offering on June 10, 2026.
Who are the main investors in ElkosRx, LLC?
Key investors in ElkosRx, LLC include Hercules Capital, EQT Life Sciences, Pontifax Venture Capital.
Will ElkosRx, LLC IPO soon?
No public IPO plans have been announced for ElkosRx, LLC.
How can I track ElkosRx, LLC secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ElkosRx, LLC's secondary market activity and sign up for updates.